University Of California Irvine

University of California Irvine, a publicly funded research institution and 1862 Land Grant College headquartered in Irvine, California, functions as a federal research recipient and service provider across a highly diversified portfolio spanning over 5,980 prime and sub-awards from 195 distinct federal agencies. UCI does not hold federal prime contracts or operate as a contractor to the Department of Defense; instead, the institution operates as a grant recipient and clinical service provider to the Department of Veterans Affairs and research partner to civilian agencies including the National Science Foundation, National Institutes of Health, NASA, and the Department of Energy.

UCI's federal footprint reflects its identity as a comprehensive research university. Recent grant work demonstrates breadth across biomedical sciences, physical sciences, engineering, and educational research. Representative awards include a $3.22 million National Institute on Aging grant (2025–2029) investigating the retrosplenial cortex's role in Alzheimer's disease pathogenesis; a $1.89 million National Institute of General Medical Sciences award (2025–2029) for developing molecular-imaging tools to track RNA dynamics in living cells; an $8.998 million National Science Foundation Cooperative Agreement (2026–2029) to establish the BRIDGE National Center for democratizing artificial intelligence and data science across research communities; a $1.285 million Department of the Army contract (2026–2030) for fast, interactive flood modeling under the Environmental Security Technology Certification Program; and recurring clinical service delivery through the Department of Veterans Affairs, including urology physician services, bioinformatics, and laboratory testing to the VA Long Beach Healthcare System.

Customer concentration reveals heavy reliance on civilian research funding. The National Science Foundation leads by award count (1,132 awards), while NASA's Shared Services Center anchors potential-value concentration at $83.4 million across 341 awards for balanced science program execution. The Department of Veterans Affairs (Veterans Integrated Service Network 22) represents the second-largest value generator at $49.9 million across 72 awards for clinical services and research support. The National Institute of Child Health and Human Development, National Institute of Allergy and Infectious Diseases, and National Institute on Aging together account for substantial research volume, reflecting UCI's strength in health sciences and aging-focused research. This customer composition is characteristic of academic medical research institutions: dispersed across many agencies, with no single funder dominating dollars or decision-making.

UCI operates as a prime recipient on the overwhelming majority of its awards (91% prime, 9% sub), positioning the institution as a research leader rather than a support contractor. The institution does not hold seats on government-wide acquisition contracts (GWACs) or IDIQs; instead, its federal relationships flow through individual grant awards, cooperative agreements, and agency-specific task orders. The single largest parent vehicle is an Indefinite Delivery Contract (N0014098G2423) generating 40 task orders valued at $370 thousand—a nominal figure reflecting the vehicle's role in research administration rather than revenue generation.

Service Contract Inventory data reveals UCI's federal service-contract activity as minimal. SCI-reportable invoiced revenue totaled $2.8 million in FY2024, supporting 3.3 FTEs on three prime contracts, with no sub-engagement. Government-paid hourly rates for professional services (physicians, biostatisticians) run approximately $409 per hour. This low SCI footprint underscores that UCI's federal engagement is driven by research grants (reported through federal grant mechanisms) rather than by billable service contracts.

Activity shows relative stability year-to-year: 310 awards in 2022, 335 in 2023, 437 in 2024, 357 in 2025, and 110 through mid-2026 (reflecting the snapshot date of 2026-07-15). The 526 awards reaching completion within the next twenty-four months (combined potential value $23 million) represent the annual churn of expiring grants requiring renewal or recompete, a standard cycle for academic research institutions where multi-year project grants are the norm.

UCI's teaming posture centers on collaborative research rather than traditional prime-sub relationships. The institution names numerous sub-grantees under its research awards—including sub-awards to University of Southern California, Yale University, University of Washington, and dozens of other institutions—reflecting the distributed, collaborative nature of federally funded biomedical and engineering research. Conversely, UCI serves as a sub-recipient on research awards from larger research consortia, such as participation in the BRIDGE data-science center (sub to a National Science Foundation cooperative agreement led by another institution) and sub-site work under NIH multi-site trials.

As a tax-exempt, state-controlled public institution, UCI does not compete under small-business set-asides (8(a), HUBZone, SDVOSB, WOSB) and does not pursue federal contracts through GSA Schedules or alliant GWACs. The institution's federal position is defined by its role as a knowledge-generating and service-delivering partner to agencies pursuing research, education, and clinical objectives aligned with civilian and defense priorities.